February 15, 2024 · Form 4 insider transaction
Reents Scott T bought 31,520 shares of AbbVie Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,507 on February 15, 2025, 10,507 on February 15, 2026, and 10,506 on February 15, 2027.